US 7902241
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted A61KA61K31/17A61K31/4166
Quick answer
US patent 7902241 (Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/17, A61K31/4166, A61K31/4172, A61K31/4196